Topics

CRISPR for Cancer; FDA's Oncology Office Rebrand; Earlier PSA Testing?

07:30 EST 7 Nov 2019 | MedPageToday

(MedPage Today) -- CRISPR makes its first foray as a cancer treatment in the U.S., with early results in three leukemia patients showing the gene-editing therapy to be safe. (AP) FDA's Office of Hematology and Oncology Products gets reshuffled...

Original Article: CRISPR for Cancer; FDA's Oncology Office Rebrand; Earlier PSA Testing?

NEXT ARTICLE

More From BioPortfolio on "CRISPR for Cancer; FDA's Oncology Office Rebrand; Earlier PSA Testing?"

Quick Search

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Leukemia
Leukemia is a type of cancer of the blood or bone marrow characterized by an abnormal increase of immature white blood cells called "blasts". Leukemia is a broad term covering a spectrum of diseases. In turn, it is part of the even broader grou...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...